Vascular dementia is one of the most common types of dementia and happens when reduced blood flow damages parts of the brain.
Unlike Alzheimer’s disease, which is mainly linked to the build-up of abnormal proteins, vascular dementia is closely connected to problems in the blood vessels that supply oxygen and nutrients to brain cells.
When blood flow is reduced over time, brain cells can become damaged, leading to memory problems, difficulty thinking clearly, and changes in daily functioning. As populations around the world continue to age, dementia is becoming a major health challenge.
Experts estimate that the number of people living with dementia worldwide could rise from about 55 million today to around 139 million by 2050, creating an urgent need for new and affordable treatments.
In an interesting new study published in the journal Alzheimer’s & Dementia, researchers explored whether tadalafil, a drug best known for treating erectile dysfunction, could potentially help people at risk of vascular dementia.
Tadalafil belongs to a family of medicines called phosphodiesterase-5 inhibitors, which also includes sildenafil, commonly known as Viagra, and vardenafil. These medicines work by relaxing blood vessels, allowing blood to flow more easily through the body.
Scientists have been interested in these drugs for several years because healthy blood flow is also important for brain function. Earlier studies suggested that drugs in this group might improve blood circulation in the brain and possibly help protect against some forms of dementia.
Tadalafil attracted particular attention because it stays active in the body longer than similar medications and may be better able to reach brain tissue.
The research was a phase II clinical trial supported by the Alzheimer’s Drug Discovery Foundation in the United States and the Alzheimer’s Society in the United Kingdom.
The study focused on older adults who had narrowing of arteries in the brain. This condition can reduce blood supply to important brain areas and increase the risk of both stroke and vascular dementia.
To examine whether tadalafil could improve blood flow in the brain, researchers used a modern brain imaging method called arterial spin labeling MRI. This technique allows scientists to measure blood flow without using injections or radioactive materials. It offers a safe way to see how well blood is reaching different parts of the brain.
Participants received either a single dose of tadalafil or a placebo, which contained no active medicine. The researchers then compared blood flow measurements between the two groups.
Overall, the study did not find a significant improvement in brain blood flow after a single dose of tadalafil. In other words, the medicine did not produce the clear positive effect that researchers had hoped to see across the entire study group.
However, the results revealed an interesting clue. Among participants who were older than 70 years, researchers noticed a small trend suggesting better blood flow in the brain’s white matter.
White matter contains nerve fibers that connect different parts of the brain and help brain cells communicate with one another. Damage to white matter is commonly seen in people with vascular dementia and is believed to play an important role in memory and thinking problems.
Another encouraging finding was the drug’s safety. Researchers reported no serious side effects among participants. This is important because treatments for older adults must be carefully evaluated to ensure they do not create additional health risks.
Since tadalafil has already been used by many people for other medical conditions, doctors have extensive information about its safety profile.
Dr. Jeremy Isaacs, a neurologist involved in the research, explained that a single dose of the drug may not be enough to produce meaningful changes in the brain. He suggested that future studies should investigate whether taking tadalafil over a longer period could lead to stronger benefits.
Dr. Atticus Hainsworth, another member of the research team, noted that finding new uses for existing medicines can greatly speed up medical progress because researchers already understand how these drugs work and how safe they are.
Katherine Gray from the Alzheimer’s Society also expressed hope that future studies will test different doses and longer treatment periods. Such research could help scientists determine whether tadalafil can improve brain health or slow the progression of vascular dementia in some patients.
Although this study did not provide a major breakthrough, it offers an important step forward. Negative or mixed results can still help guide future research and reveal promising directions. Because tadalafil is already widely available and relatively well understood, it could become a practical and affordable option if future trials demonstrate clear benefits.
For now, scientists remain cautiously optimistic. More research is needed before tadalafil can be recommended as a treatment for vascular dementia.
Still, this study highlights how familiar medicines sometimes hold unexpected possibilities. A drug originally developed for one purpose may one day contribute to protecting brain health and improving the lives of older adults facing the challenges of dementia.
If you care about brain health ,please read studies about Vitamin B9 deficiency linked to higher dementia risk, and cranberries could help boost memory.
For more health information, please see recent studies about heartburn drugs that could increase risk of dementia, and results showing this MIND diet may protect your cognitive function, prevent dementia.
Copyright © 2026 Knowridge Science Report. All rights reserved.
